Study of Potential Drug Interactions in COVID-19 Patients with Comorbid Type 2 Diabetes Mellitus at The General Hospital in South Tangerang City, Period 2021ral Hospital in South Tangerang City
Keywords:
clinical outcome, covid-19, diabetes mellitus , drug interactionAbstract
Diabetes mellitus is one of the common comorbidities found in COVID-19 patients. The use of large amounts of medication (polypharmacy) in COVID-19 patients with comorbid diabetes mellitus can increase the possibility of drug interactions. The study aimed to determine the potential drug-drug interactions and it is the relationship with clinical outcomes in COVID-19 patients with comorbid type 2 diabetes mellitus at the General Hospital in South Tangerang City. The study was a retrospective study conducted in the hospital by using patients medical records from January-December 2021. Potential drug-drug interactions were analyzed by using the software, Medscape, and Drugs.com. The 97 patients met the inclusion and exclusion criteria. The results of the study were found in 40 patients who experience drug interactions with COVID-19 drugs and antidiabetics (58.2%), the majority of them are in moderate severity degree (78.5%), major severity degree (21.5%), with pharmacodynamic mechanism (100%). There is no significant relationship between drug interactions and clinical outcomes of patients (P>0.05). The interactions found were all pharmacodynamic, although there was no significant relationship to clinical outcomes, therapeutic monitoring was still required.
References
Aladin, R. A. 2022. Pengaruh Komorbid Hipertensi Terhadap Recovery Time Pada Pasien Covid-19 di RSUP dr. M. Djamil Padang. Medan: Univeritas Muhammadiyah Sumatera Utara
Anggraini, D. 2015. Interaksi Obat Antidiabetik Dan Kaitannya Terhadap Kadar Glukosa Darah PadaPasien Diabetes Melitus Tipe 2 Yang Menjalanu Rawat Inap. Universitas Gadjah Mada, Yogyakarta.
Badan Penelitian dan Pengembangan Kesehatan. 2019. Riset Kesehatan Dasar (RISKESDAS) 2018. Kementerian Kesehatan Republik Indonesia. [https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan%20Riskesdas%202018%20Nasional.pdf].
Ciarambino, T., Crispino, P., Leto, G., Mastrolorenzo, E., Para, O., Giordano, M. 2022. Influence of Gender in Diabetes Mellitus and Its Complication. International journal of molecular sciences, 23(16), 8850. https://doi.org/10.3390/ijms23168850
Drugs.com. (2022). Drug Interactions Checker. [https://www.drugs.com/drug_interactions.html].
DiPiro, J.T., Yee, G.C., Posey, L.M., Haines, S.T., Nolin, T.D. and Ellingrod, V. 2020. Pharmacotherapy: A pathophysiologic approach. 11th edn. New York: McGraw-Hill Education.
Ermaralda, V. 2016. Pengaruh Drug Related Problem Terhadap Outcome Klinik Pasien Diabetes Melitus Di Instalasi Rawat Inap di RS X di Tangerang Selatan Periode Juli 2014-Juni 2015. Jakarta: UIN Syarif Hidayatullah.
Faizah, A. K., Wuryana, D. 2018. Kajian Interaksi Obat Pada Pasien Pneumonia Di Rs PendidikanSurabaya. Scientia : Jurnal Farmasi Dan Kesehatan, 8(1), 89.Genomics, 13(1), 2. https://doi.org/10.1186/s40246-018-0185-z
Haryati, H., Isa, M., Assagaf, A., Nurrasyidah, I. and Kusumawardhani, E. 2021. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 in Ulin Regional Hospital Banjarmasin, Jurnal Respirasi, 7(1), pp. 1–7. doi: 10.20473/jr.v7-I.1.2021.1-7.
Hikmawati, I., Setiyabudi, R. 2020. Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia Hypertension and Diabetes Mellitus As Covid-19 Comorbidities in Indonesia. Prosiding Seminar Nasional
Iloanusi, S., Mgbere, O., & Essien, E. J. 2021. Polypharmacy among COVID-19 patients: A systematicreview. Journal of the American Pharmacists Association, 61(5), e14–e25. https://doi.org/10.1016/j.japh.2021.05.006
J. C., Haagmans, B. L. 2010. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathogens,6(2). https://doi.org/10.1371/journal.ppat.1000756
Kementerian Kesehatan Republik Indonesia. 2020. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (Covid-19). Jakarta: Germas Kemenkes RI.
Kementerian Kesehatan Republik Indonesia. 2021. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/5671/2021 Tentang Manajemen Klinis Tata Laksana Corona Virus Disease 2019 (Covid-19) Di Fasilitas Pelayanan Kesehatan. internet, Indonesia
Koh, Y., Kutty, F. B., & Li, S. C. 2005. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Therapeutics and clinical risk management, 1(1), 39–48. https://doi.org/10.2147/tcrm.1.1.39.53597
Lipsky, M. S., & Hung, M. 2020. Men and COVID-19: A Pathophysiologic Review. American Journal of Men’s Health, 14(5). https://doi.org/10.1177/1557988320954021
Maulidia, S. S., Mahmudah, F. and Sastyarina, Y. 2021. Kajian Potensi Interaksi Obat pada Pasien COVID-19 di Rumah Sakit X Kota Samarinda: Study of Potential Drug Interactions in COVID-19 Patients at Hospital X Samarinda City, Proceeding of Mulawarman Pharmaceuticals Conferences, 14(1), pp. 295–301. doi: 10.25026/mpc.v14i1.587.
Medscape. 2022. Drug Interactions Checker - Medscape Drug Reference Database. Retrieved May 30,2022, https://reference.medscape.com/drug-interactionchecker
Rawitri, K., Wahyuni, Sri., and Sari, S. R. 2022. Analysis of Potential Drug Interaction in Prescribing Type 2 DiabetesMellitus Patients at a Pharmacya in Medan City. International Journal of Health and Pharmaceutical. 3 (1).
Schurz, H., Salie, M., Tromp, G., Hoal, E. G., Kinnear, C. J., & Möller, M. 2019. The X chromosome and sex-specific effects in infectious disease susceptibility. Human genomics, 13(1), 2. https://doi.org/10.1186/s40246-018-0185-z
Singh, A. K., Gupta, R., Ghosh, A., & Misra, A. 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & metabolic syndrome, 14(4), 303–310. https://doi.org/10.1016/j.dsx.2020.04.004
Smits, S. L., de Lang, A., van den Brand, J. M., Leijten, L. M., van IJcken, W. F., Eijkemans, M. J., van Amerongen, G., Kuiken, T., Andeweg, A. C., Osterhaus, A. D., & Haagmans, B. L. (2010). Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS pathogens, 6(2), e1000756. https://doi.org/10.1371/journal.ppat.1000756
Thanacoody, R. 2019. Drug Interactions. In Clinical Pharmacy and Therapeutics. The Netherlands: Elsevier.
Yuniar, Y., Ramadhiani, A.R., Asyifa, D., Putri, W.K.A., Apriliana, W.S,. 2022. Potensi Interaksi Obat Pada Pasien Covid-19 Terkonfirmasi Dengan Komorbid di Bangsal Ogan RSUP Dr. Mohammad Hoesin Palembang Periode April-Juni 2021. Majalah Farmaseutik. 18. 43. 10.22146/farmaseutik.v18i1.71910.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nurmeilis Nurmeilis, yusroh umami, nurhaida nurhaida
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
